Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer

NCT04134312 is registered in ClinicalTrials.gov with Bavarian Nordic as lead sponsor.

NCT NCT04134312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04134312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer
Lead sponsor
Bavarian Nordic
Phase
Phase 1
Overall status
Completed
Start date
January 8, 2020
Completion date
April 6, 2021
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid metastatic tumor